Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia.
A retrospective survey of the use of benzodiazepines by 149 outpatients with schizophrenia found that 59% were on neuroleptics alone and 41% were receiving both neuroleptics and benzodiazepines. Of the group receiving both, 64% were taking a benzodiazepine as a hypnotic agent; 23% of those were taking alprazolam as an anxiolytic. The patients taking neuroleptics and alprazolam required significantly less neuroleptic medication than the group receiving neuroleptics alone.
Pecknold
J C
JC
Douglas Hospital Research Centre, Verdun, Quebec, Canada.
D000328:Adult; D000368:Aged; D000525:Alprazolam / Q000627:therapeutic use; D000553:Ambulatory Care; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D000525:Alprazolam